DIABETA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Diabeta, and when can generic versions of Diabeta launch?
Diabeta is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in DIABETA is glyburide. There are twenty drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the glyburide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Diabeta
A generic version of DIABETA was approved as glyburide by TEVA on August 29th, 1995.
Summary for DIABETA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 152 |
Clinical Trials: | 6 |
Patent Applications: | 3,596 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DIABETA at DailyMed |
Recent Clinical Trials for DIABETA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Kentucky | Phase 1 |
Ohio State University | Phase 1/Phase 2 |
Texas Tech University Health Sciences Center, El Paso | Early Phase 1 |
US Patents and Regulatory Information for DIABETA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | DIABETA | glyburide | TABLET;ORAL | 017532-001 | May 1, 1984 | AB2 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Sanofi Aventis Us | DIABETA | glyburide | TABLET;ORAL | 017532-002 | May 1, 1984 | AB2 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Sanofi Aventis Us | DIABETA | glyburide | TABLET;ORAL | 017532-003 | May 1, 1984 | AB2 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DIABETA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | DIABETA | glyburide | TABLET;ORAL | 017532-002 | May 1, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | DIABETA | glyburide | TABLET;ORAL | 017532-002 | May 1, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | DIABETA | glyburide | TABLET;ORAL | 017532-001 | May 1, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | DIABETA | glyburide | TABLET;ORAL | 017532-003 | May 1, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DIABETA
See the table below for patents covering DIABETA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Austria | 262309 | ⤷ Try a Trial | |
Austria | 267541 | ⤷ Try a Trial | |
Netherlands | 7304110 | ⤷ Try a Trial | |
Spain | 355477 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |